Australia markets open in 7 hours 31 minutes

Berry Global Group, Inc. (BERY)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
61.44+0.49 (+0.80%)
As of 12:29PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close60.95
Open60.71
Bid61.42 x 800
Ask61.44 x 800
Day's range60.71 - 61.51
52-week range53.92 - 69.94
Volume482,309
Avg. volume1,139,981
Market cap7.123B
Beta (5Y monthly)1.23
PE ratio (TTM)13.36
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yield1.10 (1.80%)
Ex-dividend date29 Feb 2024
1y target estN/A
  • Business Wire

    Berry Declares Quarterly Dividend

    EVANSVILLE, Ind., May 07, 2024--Berry Global Group, Inc.’s (NYSE: BERY) board of directors today declared a quarterly cash dividend of $0.275 per share. The payment date is June 17, 2024, to stockholders of record as of June 3, 2024.

  • PR Newswire

    NewHold Enterprises Announces Sale of F&S Tool to Berry Global

    NewHold Enterprises, an operationally focused investment firm, is pleased to announce the sale of F&S Tool, a leading North American designer and manufacturer of precision injection molding tools, to Berry Global Group, Inc. (NYSE: BERY). F&S Tool operates a 90,000 square foot facility located in Erie, Pennsylvania, with 11 issued/pending patents and 105 employees focused on proprietary technologies to serve a large and diverse addressable market. The sale was completed on April 05, 2024.

  • Business Wire

    Berry and Glatfelter Announce Regulatory Milestone in Proposed Transaction for Spin-Off and Merger of Berry’s Health, Hygiene and Specialties Global Nonwovens and Films Business with Glatfelter

    EVANSVILLE, Ind., April 17, 2024--Berry Global Group, Inc. (NYSE: BERY) and Glatfelter Corporation (NYSE: GLT) announced today the achievement of a regulatory milestone in the proposed transaction involving the combination of a majority of Berry’s Health, Hygiene and Specialties segment to include its Global Nonwovens and Films business ("HHNF") with Glatfelter, with the expiration of the required waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act.